Skip to Content

W975 (Divalproex 500 mg)

Pill imprint W975 has been identified as Divalproex sodium delayed-release 500 mg.

Divalproex sodium is used in the treatment of bipolar disorder; migraine prevention; mania; epilepsy; borderline personality disorder (and more), and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 500 mg is not a controlled substance under the Controlled Substance Act (CSA).

Divalproex sodium delayed-release
Imprint:
W975
Strength:
500 mg
Color:
White
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Fatty acid derivative anticonvulsants
Pregnancy Category:
D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder
X - Not for use in pregnancy - When treating migraine
CSA Schedule:
Not a controlled drug
Manufacturer:
Wockhardt USA
National Drug Code (NDC):
64679-0975
Inactive Ingredients:
silicon dioxide
microcrystalline cellulose
corn starch
povidone
croscarmellose sodium
glyceryl behenate
magnesium silicate
hypromelloses
polyethylene glycol
polyvinyl alcohol
polysorbate 80
methacrylic acid - ethyl acrylate copolymer (1:1) type a
triethyl citrate
sodium bicarbonate
sodium lauryl sulfate
dimethicone
titanium dioxide

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide